Trial Profile
Safety of Levemir (Insulin Detemir) Treatment in Patients With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2014
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 01 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jun 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 11 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.